EISAI CO
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public
- Established
- 1941-12-06
- Employees
- 11K
- Market Cap
- $12B
- Website
- http://www.eisai.co.jp
A Study of E7080 in Subjects With Solid Tumor
- First Posted Date
- 2010-12-30
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 9
- Registration Number
- NCT01268293
Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori
Completed
- Conditions
- Gastric Low-grade MALT Lymphoma With Helicobacter Pylori Positive
- Interventions
- First Posted Date
- 2010-12-22
- Last Posted Date
- 2017-02-27
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 108
- Registration Number
- NCT01264822
E2022 Patch Formulation Single Dose Phase I Study
- First Posted Date
- 2010-12-03
- Last Posted Date
- 2013-05-14
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT01253434
Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease
- First Posted Date
- 2010-12-02
- Last Posted Date
- 2023-07-24
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 894
- Registration Number
- NCT01251718
A Clinical Pharmacological Study of Rabeprazole Sodium in Japanese Healthy Adult Male Volunteers (Study E3810)
Phase 2
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2010-09-15
- Last Posted Date
- 2012-11-30
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT01202071
An Study of Efficacy and Safety of Clevudine
- First Posted Date
- 2010-09-01
- Last Posted Date
- 2013-05-14
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 288
- Registration Number
- NCT01192854
- Locations
- 🇨🇳
Xiangya hospital, Changsha, Hunan, China
Safety and Efficacy of Mecobalamin Injection in Peripheral Neuropathies Patients (Study JGAZSY091109)
Phase 4
Completed
- Conditions
- Peripheral Neuropathy
- Interventions
- First Posted Date
- 2010-08-31
- Last Posted Date
- 2012-11-07
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 1072
- Registration Number
- NCT01192113
- Locations
- 🇨🇳
the 2nd Hospital of Suzhou University, Suzhou, Jiangsu, China
🇨🇳Subei People Hospital, Yangzhou, Jiangsu, China
🇨🇳The 1st People Hospital of Yangzhou, Yangzhou, Jiangsu, China
Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer
- First Posted Date
- 2010-08-27
- Last Posted Date
- 2013-04-01
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 1184
- Registration Number
- NCT01190657
- Locations
- 🇨🇳
Wuhan Union Hospital, Hubei, China
🇨🇳Changsha Central Hospital, Hunan, China
🇨🇳Hunan Provincial People's Hospital, Hunan, China
A Long Term Extension Study of E2080 in Lennox-Gastaut Patients
- First Posted Date
- 2010-06-28
- Last Posted Date
- 2019-03-11
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 54
- Registration Number
- NCT01151540
Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-
- First Posted Date
- 2010-05-24
- Last Posted Date
- 2018-11-05
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 10238
- Registration Number
- NCT01129596